NCT05611346Active, not recruiting
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers : Study Protocol of a Pilot Randomized and Controlled Trial
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 3 Nov 2022
- Start date
- 13 Aug 2024
- Primary completion date
- Feb 2027
- Lead sponsor
- Centre Hospitalier Universitaire de la Réunion
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT05611346
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 13 Aug 2024 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a contraindication to hypnosis (psychiatric disorders, psychosis)
Other
- Children refusing to participate in the hypnosis session
- Not having the possibility to listen to an audio file,
- Already practicing self-hypnosis for their AD before inclusion,
- Treated by a systemic treatment for their AD.
Who the study is looking for
- Children aged 8 to 17 years
- Understanding french
- Have a clinical diagnosis of mild-to-severe AD with a SCORing Atopic Dermatitis (SCORAD)
- Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion University Hospital. - Oral consent of the child and of one of the legal representatives collected.
Age in the registry: 8 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de La Réunion Coordinator of this site? Confirm its status | Saint-Denis | Réunion | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.